WAM
AMED

Wealthspire Advisors (Maryland)’s Amedisys AMED Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8
Closed -$1K – 524
2019
Q1 		$1K Sell
8
-71
-90% -$8.91K ﹤0.01% 2285
2018
Q4 		$9K Sell
79
-1
-1% -$118 ﹤0.01% 1492
2018
Q3 		$10K Buy
80
+11
+16% +$1.22K ﹤0.01% 1503
2018
Q2 		$6K Buy
69
+13
+23% +$955 ﹤0.01% 1700
2018
Q1 		$3K Buy
56
+4
+8% +$228 ﹤0.01% 1985
2017
Q4 		$3K Buy
52
+18
+53% +$949 ﹤0.01% 1964
2017
Q3 		$2K Sell
34
-16
-32% -$846 ﹤0.01% 1953
2017
Q2 		$3K Buy
+50
New +$2.91K ﹤0.01% 1876

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s AMED Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Amedisys (AMED) in Q2 2019, closing a stake of 8 shares — an estimated $1K sold.

Wealthspire Advisors (Maryland) first reported a position in AMED in Q2 2017 and held it in 8 quarters. The position peaked at $10K in Q3 2018. 285 funds tracked by Wall St. Rank hold AMED as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Amedisys position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 8 Amedisys shares in Q2 2019, an estimated $1K.
  • Wealthspire Advisors (Maryland) first reported a position in Amedisys in Q2 2017 and held it in 8 quarters.
  • Wealthspire Advisors (Maryland)'s Amedisys position peaked at $10K in Q3 2018.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.